Advertisement
Advertisement

PIRS

PIRS logo

Pieris Pharmaceuticals Inc

13.63
USD
-2.50
-15.50%
Dec 13, 15:33 UTC -5
Closed
...

Pieris Pharmaceuticals Inc Profile

About

Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.

Info & Links

CEO

Stephen S. Yoder

Headquarters

225 Franklin Street, 26th Floor
Boston, MA 02110, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

31

Employees

50

Pieris Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization2

17.99M

Enterprise Value

-1.37M

Enterprise Value/EBITDA(ttm)

0.08

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.44

Price to Book(mrq)

1.10

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

-42.11%

Profit Margin(ttm)

-2395.77%

Return on Equity(ttm)

-80.93%

Return on Invested Capital(ttm)

-76.34%

Return on Assets(ttm)

-59.55%

Income Statement

Revenue(ttm)

1.35M

Revenue Per Share(ttm)

1.02

Gross Profit(ttm)

1.35M

EBITDA(ttm)3

-17.34M

Net Income Available to Common(ttm)

-15.95M

Diluted EPS(ttm)

-12.10

Share Statistics

Beta (5Y Monthly)

0.61

52-Week Change

-14.77%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.32M

Dividend Yield

0.00%

Float4

1.24M

% Held by Insiders

6.39%

% Held by Institutions

40.11%

Balance Sheet

Total Cash(mrq)

19.36M

Total Cash Per Share(mrq)

14.67

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.82%

Quick Ratio(mrq)

4.82%

Book Value Per Share(mrq)

12.32

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.31

Free Cash Flow(ytd)

-6.01M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement